SG11201809197XA - Compositions for use in treating tendon degeneration - Google Patents
Compositions for use in treating tendon degenerationInfo
- Publication number
- SG11201809197XA SG11201809197XA SG11201809197XA SG11201809197XA SG11201809197XA SG 11201809197X A SG11201809197X A SG 11201809197XA SG 11201809197X A SG11201809197X A SG 11201809197XA SG 11201809197X A SG11201809197X A SG 11201809197XA SG 11201809197X A SG11201809197X A SG 11201809197XA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- pct
- street
- compositions
- treating
- Prior art date
Links
- 210000002435 tendon Anatomy 0.000 title abstract 3
- 230000007850 degeneration Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000007972 injectable composition Substances 0.000 abstract 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000036571 hydration Effects 0.000 abstract 1
- 238000006703 hydration reaction Methods 0.000 abstract 1
- 238000005461 lubrication Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 102220240796 rs553605556 Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/386—Ligaments, tendons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662328396P | 2016-04-27 | 2016-04-27 | |
| US201662367377P | 2016-07-27 | 2016-07-27 | |
| PCT/US2017/029635 WO2017189723A1 (en) | 2016-04-27 | 2017-04-26 | Compositions for use in treating tendon degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201809197XA true SG11201809197XA (en) | 2018-11-29 |
Family
ID=58709560
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809197XA SG11201809197XA (en) | 2016-04-27 | 2017-04-26 | Compositions for use in treating tendon degeneration |
| SG10201913342UA SG10201913342UA (en) | 2016-04-27 | 2017-04-26 | Compositions for use in treating tendon degeneration |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201913342UA SG10201913342UA (en) | 2016-04-27 | 2017-04-26 | Compositions for use in treating tendon degeneration |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10441677B2 (https=) |
| EP (1) | EP3448394B1 (https=) |
| JP (1) | JP6826657B2 (https=) |
| KR (1) | KR20190009303A (https=) |
| CN (1) | CN109562124A (https=) |
| AU (1) | AU2017257956B2 (https=) |
| CA (1) | CA3021764C (https=) |
| IL (1) | IL262507B (https=) |
| MX (1) | MX375382B (https=) |
| NZ (1) | NZ747413A (https=) |
| RU (1) | RU2018141386A (https=) |
| SG (2) | SG11201809197XA (https=) |
| TW (2) | TW202114712A (https=) |
| WO (1) | WO2017189723A1 (https=) |
| ZA (1) | ZA201807136B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3735204B1 (en) | 2018-01-02 | 2023-09-06 | Cartiheal (2009) Ltd. | Implantation tool for optimized solid substrates promoting cell and tissue growth |
| JP2024006681A (ja) * | 2022-07-04 | 2024-01-17 | 学校法人近畿大学 | 生体材料 |
| KR102940883B1 (ko) * | 2022-12-27 | 2026-03-17 | 차의과학대학교 산학협력단 | 비타민 d를 포함하는 건병증 또는 근육손상 치료용 히알루론산 하이드로겔계 약물 전달 시스템 및 이의 제조방법 |
| WO2025096427A1 (en) * | 2023-10-29 | 2025-05-08 | Brown David Donaldson | Methods for treating lower back pain with hyaluronic acid |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2946819A (en) | 1958-04-14 | 1960-07-26 | Gen Aniline & Film Corp | Process of producing carbodimides |
| DE1156401B (de) | 1960-05-24 | 1963-10-31 | Bayer Ag | Verfahren zur Herstellung von Carbodiimiden |
| DE1149712B (de) | 1961-11-14 | 1963-06-06 | Bayer Ag | Verfahren zur Herstellung von Carbodiimiden |
| US3644456A (en) | 1964-08-12 | 1972-02-22 | Upjohn Co | Di((isocyanatobenzyl)-phenyl) carbodiimides and preparation of organic carbodiimides |
| US3972933A (en) | 1974-05-28 | 1976-08-03 | Monsanto Company | Preparation of carbodiimides from ureas by dehydration |
| GB1476088A (en) | 1975-04-03 | 1977-06-10 | Ici Ltd | Carbodiimides |
| DE2556760A1 (de) | 1975-12-17 | 1977-06-30 | Hoechst Ag | Verfahren zur herstellung von carbodiimiden |
| GB1584153A (en) | 1976-09-22 | 1981-02-04 | Ici Ltd | Carbodimides |
| US4066629A (en) | 1976-10-28 | 1978-01-03 | Celanese Corporation | Process for preparing carbodiimides utilizing a phosphonium salt catalyst |
| US4098973A (en) | 1977-01-31 | 1978-07-04 | The Upjohn Company | Compounds and process |
| US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
| US5356883A (en) | 1989-08-01 | 1994-10-18 | Research Foundation Of State University Of N.Y. | Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
| ITPD940054A1 (it) | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
| DK0971961T3 (da) | 1997-04-04 | 2003-03-24 | Fidia Advanced Biopolymers Srl | N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling |
| ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
| ATE243049T1 (de) | 1999-12-09 | 2003-07-15 | Biosyntech Canada Inc | Mineral-polymer hybrid-zusammensetzung |
| CA2416126C (en) | 2000-07-28 | 2011-07-05 | Anika Therapeutics, Inc. | Bioabsorbable composites of derivatized hyaluronic acid |
| IT1317358B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Derivati cross-linkati dell'acido ialuronico. |
| IT1317359B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e |
| ATE312076T1 (de) | 2001-02-22 | 2005-12-15 | Anika Therapeutics Inc | Thiol-modifizierte hyaluronan-derivate |
| US20060272221A1 (en) | 2001-11-29 | 2006-12-07 | Treibacher Schleifmittel Gmbh | Al2O3 and ZrO2 based abrasive grain, method for the production and use thereof |
| JP4489437B2 (ja) | 2002-02-21 | 2010-06-23 | エンセル，インコーポレイテッド | 表面コーティングとしての固定化生物活性ヒドロゲルマトリックス |
| ITPD20020064A1 (it) | 2002-03-12 | 2003-09-12 | Fidia Advanced Biopolymers Srl | Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem |
| DE60305036T2 (de) | 2002-06-19 | 2006-10-12 | Dr. H.C. Robert Mathys Stiftung | Hydraulischer zement auf basis von calciumphosphat für chirurgische anwendungen |
| US8455458B2 (en) | 2002-10-16 | 2013-06-04 | Arthrodynamic Technologies, Animal Health Division, Inc. | Composition and method for treating connective tissue damage |
| DE10257554B4 (de) | 2002-12-10 | 2008-04-10 | Treibacher Schleifmittel Gmbh | Schleifkörner mit einer Ummantelung aus einem wässrigen Bindemittel und einer komplexen feinkörnigen Oxidverbindung, Verfahren zur Behandlung derartiger Schleifkörner sowie ihre Verwendung für kunstharzgebundene Schleifmittel |
| ES2317018T3 (es) | 2003-10-09 | 2009-04-16 | Robert John Petrella | Procedimiento para el tratamiento de un esguince y una distension agudos o debidos a una utilizacion excesiva utilizando acido hialuronico. |
| US8124120B2 (en) | 2003-12-22 | 2012-02-28 | Anika Therapeutics, Inc. | Crosslinked hyaluronic acid compositions for tissue augmentation |
| WO2007070547A2 (en) | 2005-12-14 | 2007-06-21 | Anika Therapeutics, Inc. | Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
| EP1891984A1 (en) | 2006-08-24 | 2008-02-27 | Graftys | Macroporous and highly resorbable apatitic calcium-phosphate cement |
| IT1393419B1 (it) | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
| DK2480075T3 (da) * | 2009-09-23 | 2020-09-28 | Glenpharma Ab | Sammensætninger og fremgangsmåder til at fremkalde eller forbedre reparation af bindevæv |
| BR112012020566B1 (pt) * | 2010-02-22 | 2021-09-21 | Biomimetic Therapeutics, Llc | Composição de fator de crescimento derivado de plaqueta |
| CN103841927A (zh) | 2011-06-09 | 2014-06-04 | 齐默尔膝部创造物公司 | 用于软骨下关节修复的器械和装置 |
| MX368000B (es) | 2012-03-22 | 2019-09-13 | Trb Chemedica Int S A | Composición de colágeno y ácido hialurónico para la reparación de ligamento o tendón. |
| PL2900247T3 (pl) * | 2012-09-26 | 2018-05-30 | Bone Therapeutics S.A. | Kompozycje zawierające osocze poddane obróbce rozpuszczalnikiem/detergentem i kwas hialuronowy do zastosowania w leczeniu zaburzeń układu mięśniowo-szkieletowego |
| EP3107590B1 (en) * | 2014-02-20 | 2021-11-17 | Ortho Regenerative Technologies Inc. | Freeze-dried polymer compositions for mixing with platelet rich plasma to form implants for tissue repair and/or compositions for therapeutic intra-articular injections |
-
2017
- 2017-04-26 CA CA3021764A patent/CA3021764C/en active Active
- 2017-04-26 EP EP17723815.1A patent/EP3448394B1/en active Active
- 2017-04-26 SG SG11201809197XA patent/SG11201809197XA/en unknown
- 2017-04-26 RU RU2018141386A patent/RU2018141386A/ru unknown
- 2017-04-26 US US15/497,577 patent/US10441677B2/en active Active
- 2017-04-26 SG SG10201913342UA patent/SG10201913342UA/en unknown
- 2017-04-26 AU AU2017257956A patent/AU2017257956B2/en active Active
- 2017-04-26 MX MX2018012964A patent/MX375382B/es active IP Right Grant
- 2017-04-26 JP JP2019508158A patent/JP6826657B2/ja active Active
- 2017-04-26 WO PCT/US2017/029635 patent/WO2017189723A1/en not_active Ceased
- 2017-04-26 NZ NZ747413A patent/NZ747413A/en unknown
- 2017-04-26 CN CN201780039455.6A patent/CN109562124A/zh active Pending
- 2017-04-26 KR KR1020187033872A patent/KR20190009303A/ko not_active Ceased
- 2017-04-27 TW TW109130386A patent/TW202114712A/zh unknown
- 2017-04-27 TW TW106114071A patent/TWI755392B/zh active
-
2018
- 2018-10-22 IL IL262507A patent/IL262507B/en active IP Right Grant
- 2018-10-25 ZA ZA2018/07136A patent/ZA201807136B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3021764C (en) | 2021-01-19 |
| ZA201807136B (en) | 2021-05-26 |
| TW201739457A (zh) | 2017-11-16 |
| IL262507B (en) | 2020-10-29 |
| MX375382B (es) | 2025-03-06 |
| EP3448394C0 (en) | 2023-09-13 |
| TWI755392B (zh) | 2022-02-21 |
| US10441677B2 (en) | 2019-10-15 |
| SG10201913342UA (en) | 2020-03-30 |
| AU2017257956B2 (en) | 2019-11-07 |
| US20170326271A1 (en) | 2017-11-16 |
| JP2019516784A (ja) | 2019-06-20 |
| TW202114712A (zh) | 2021-04-16 |
| RU2018141386A (ru) | 2020-05-27 |
| CA3021764A1 (en) | 2017-11-02 |
| NZ747413A (en) | 2020-09-25 |
| EP3448394B1 (en) | 2023-09-13 |
| WO2017189723A1 (en) | 2017-11-02 |
| CN109562124A (zh) | 2019-04-02 |
| IL262507A (en) | 2018-12-31 |
| JP6826657B2 (ja) | 2021-02-03 |
| KR20190009303A (ko) | 2019-01-28 |
| MX2018012964A (es) | 2019-06-10 |
| EP3448394A1 (en) | 2019-03-06 |
| RU2018141386A3 (https=) | 2020-05-27 |
| AU2017257956A1 (en) | 2018-11-15 |
| WO2017189723A9 (en) | 2018-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201805888SA (en) | Cyclic dinucleotides for treating conditions associated with sting activity such as cancer | |
| SG11201806302RA (en) | Inhibitors of receptor-interacting protein kinase 1 | |
| SG11201804373VA (en) | Compositions and methods for immunooncology | |
| SG11201906853QA (en) | Anti-rsv monoclonal antibody formulation | |
| SG11201908330PA (en) | Farnesoid x receptor agonists and uses thereof | |
| SG11201811564QA (en) | Methods of treating ovarian cancer | |
| SG11201809875VA (en) | Compositions and methods for treating spinal muscular atrophy | |
| SG11201909825VA (en) | Hsp90 inhibitor oral formulations and related methods | |
| SG11201804901WA (en) | Compounds for the treatment of cancer and inflammatory disease | |
| SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201907604UA (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
| SG11201809202XA (en) | Methods and compositions for the treatment of degenerate bone | |
| SG11201807913XA (en) | Stabilized soluble pre-fusion rsv f proteins | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201809197XA (en) | Compositions for use in treating tendon degeneration | |
| SG11201902531QA (en) | Liquid pharmaceutical composition | |
| SG11201808829VA (en) | Tdp-43 mitochondrial localization inhibitor for the treatment of neurodegenerative disease | |
| SG11201903236SA (en) | Lasofoxifene treatment of er+ breast cancer | |
| SG11201903885RA (en) | Secure key management | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
| SG11201809749VA (en) | Computer systems and methods for implementing in-memory data structures | |
| SG11201810078PA (en) | Stabilized pre-fusion rsv f proteins | |
| SG11201901925RA (en) | Methods of treating acute kidney injury |